Embecta

Yahoo Finance • 3 days ago

Stocks making the biggest moves midday: Dell, Arrowhead Pharmaceuticals, Urban Outfitters & more

Check out the companies making the biggest moves midday: Arrowhead Pharmaceuticals — The stock popped 19% after the biopharmaceutical company reported fiscal year revenue that beat analyst expectations. Arrowhead's top line for the period... Full story

Yahoo Finance • 4 days ago

Embecta declares $0.15 dividend

* Embecta (EMBC [https://seekingalpha.com/symbol/EMBC]) declares $0.15/share quarterly dividend [https://seekingalpha.com/pr/20319346-embecta-announces-quarterly-cash-dividend], in line with previous. * Forward yield [https://seekingal... Full story

Yahoo Finance • 5 days ago

Embecta gives mixed Q4 numbers, gives 2026 guidance

* Embecta press release [https://seekingalpha.com/pr/20319346-embecta-announces-quarterly-cash-dividend] (EMBC [https://seekingalpha.com/symbol/EMBC]): Q4 Non-GAAP EPS of $0.50 beats by $0.04. * Revenue of $263.3M (-8.0% Y/Y) misses by... Full story

Yahoo Finance • 5 days ago

Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance

PARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and twelve-month periods ended September 30, 2... Full story

Yahoo Finance • 5 days ago

embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. T... Full story

Yahoo Finance • 12 days ago

embecta announces changes to Board of Directors

PARSIPPANY, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced th... Full story

Yahoo Finance • 16 days ago

embecta Announces Major New Commitment to Direct Relief on World Diabetes Day

PARSIPPANY, N.J., Nov. 14, 2025 (GLOBE NEWSWIRE) -- On World Diabetes Day, embecta Corp. (“embecta”) (Nasdaq: EMBC), the largest manufacturer of insulin injection devices in the world, today announced a significant expansion of its partn... Full story

Yahoo Finance • 3 months ago

Insulin Delivery Device Company Evaluation Report 2025 | Embecta, Novo Nordisk, and Ypsomed Lead with Innovative Injection and Digital Management Solutions

Company Logo The Insulin Delivery Devices Companies Quadrant presents a detailed analysis of the global insulin delivery devices market, spotlighting the top 25 companies like Embecta Corp, Novo Nordisk, and Ypsomed as quadrant leaders. T... Full story

Yahoo Finance • 3 months ago

embecta to Participate in Investor Events

PARSIPPANY, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced th... Full story

Yahoo Finance • 4 months ago

Mizuho raises Embecta stock price target to $14 on strong Q3 results

Investing.com - Mizuho raised its price target on Embecta (NASDAQ:EMBC) to $14.00 from $12.00 on Monday, while maintaining a Neutral rating on the medical device company’s stock. According to InvestingPro data, the company currently trad... Full story

Yahoo Finance • 4 months ago

Embecta Corp (NASDAQ:EMBC) Surpasses Q3 Earnings Estimates, Shares Jump 10.5% in Pre-Market Trading

Embecta Corp (NASDAQ:EMBC [https://www.chartmill.com/stock/quote/EMBC]) reported its third-quarter fiscal 2025 earnings, surpassing analyst expectations on both revenue and earnings per share (EPS). The company’s performance has triggered... Full story

Yahoo Finance • 4 months ago

Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results

PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and nine month periods ended June 30, 2025. "Q... Full story

Yahoo Finance • 4 months ago

embecta to Report Fiscal Third Quarter 2025 Financial Results

PARSIPPANY, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a confer... Full story

Yahoo Finance • 5 months ago

Mizuho Lowers PT on Embecta Corp. (EMBC) to $13 From $15, Keeps a Neutral Rating

Embecta Corp. (NASDAQ:EMBC) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On May 23, Mizuho lowered the firm’s price target on Embecta Corp. (NASDAQ:EMBC) to $13 from $15, keeping a Neutral rating on the shares. The... Full story

Yahoo Finance • 5 months ago

Embecta Corp. (EMBC) Lowered FY25 Guidance Amid Foreign Exchange Challenges

River Road Asset Management, an investment management company, released its “River Road Small Cap Value Fund” Q1 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, AMG River Road Small Cap Value Fund (... Full story

Yahoo Finance • 6 months ago

embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day

PARSIPPANY, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta"; "The Company") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host its inaugural Analyst and Investor Day today... Full story

Yahoo Finance • 7 months ago

embecta to Report Fiscal Second Quarter 2025 Financial Results

PARSIPPANY, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal second quarter 20... Full story

Yahoo Finance • 8 months ago

Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations

PARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new landmark publication in the Mayo Clinic Proce... Full story

Yahoo Finance • 9 months ago

embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that Jake Elguicze, embecta’s Chief Financial Officer, will present at the J.P. Morgan Global Leveraged Finance Conference in Miam... Full story

Yahoo Finance • 10 months ago

Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results

PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month period ended December 31, 2024. "Buildin... Full story